Bay J O, Udar N, Bignon Y J, Gatti R A
Service d'oncologie médicale, laboratoire d'oncologie moléculaire, Inserm CRI 9402, Clermont-Ferrand, France.
Bull Cancer. 1996 Mar;83(3):171-5.
Ataxia telangiectasia (AT) is a genetic disorder with an autosomic recessive transmission. Occurring during childhood, it affects different organs and/or systems. Physiopathology is still unclear. The first clinical signs are evident early in childhood and evolution always leads to death. The secondary cause of mortality in 10 to 15% of the affected is the development of cancers. Genetic predisposition to cancer for homozygotes, as well as for heterozygotes, is one of the most remarkable aspects of this disease. For heterozygotes the risk of cancer is three times that of the norm. The gene responsible for the disease has been cloned. Its function may resolve some questions, and provide the link between degenerative process, cancer susceptibility and immunodeficiency evident in AT patients.
共济失调毛细血管扩张症(AT)是一种常染色体隐性遗传的遗传性疾病。它在儿童期发病,会影响不同的器官和/或系统。其病理生理学仍不清楚。最初的临床症状在儿童早期就很明显,病情发展最终总会导致死亡。10%至15%的患者死亡的次要原因是癌症的发生。纯合子以及杂合子患癌的遗传易感性是这种疾病最显著的特征之一。对于杂合子来说,患癌风险是正常人的三倍。导致该疾病的基因已被克隆。其功能可能会解决一些问题,并揭示AT患者中明显存在的退化过程、癌症易感性和免疫缺陷之间的联系。